Sessa Capital IM, L.P.
Q2 2022 13F-HR Holdings
Net value change ($000)
-258,998
(-12.4%)
New positions
3
Sold out positions
11
Turnover %
47.0%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| WBD | 293,458 | NEW |
| EMBC | 91,805 | NEW |
| EQH | 66,034 | 57.6% |
| FDX | 28,339 | NEW |
| GTX | 3,732 | 7.5% |
| RXST | 279 | 13.7% |
| VREX | 114 | 0.5% |
Top Reduces (Value $000, Stocks/ETFs)
| CC | -124,404 | -56.2% |
| WBD | -112,842 | -100.0% |
| CTVA | -65,775 | -65.4% |
| DTM | -50,817 | -100.0% |
| ONL | -48,155 | -76.2% |
| T | -44,917 | -17.0% |
| JXN | -39,948 | -100.0% |
| WBD | -32,620 | -100.0% |
| Provention Bio, Inc. | -19,920 | -45.4% |
| Gores Guggenheim, Inc. | -11,370 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
346,114
(18.9% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|